These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33372526)

  • 1. Association Between Low Muscle Mass and Prognosis of Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Kim CH; Rhee TM; Woo Park K; Soon Park C; Kang J; Han JK; Yang HM; Kang HJ; Koo BK; Kim HS
    J Am Heart Assoc; 2021 Jan; 10(1):e018554. PubMed ID: 33372526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
    Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
    BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive effect of estimated glomerular filtrate rate by creatinine or cystatin C on mortality in patients with coronary artery disease.
    Chen S; Zhou Y; Liang G; Wu W; Huang Z; Shi L; Gao Y; Gu X; Wang D
    Ren Fail; 2024 Dec; 46(1):2327494. PubMed ID: 38566467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
    Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
    Ide H; Iwase M; Fujii H; Ohkuma T; Kaizu S; Jodai T; Kikuchi Y; Idewaki Y; Sumi A; Nakamura U; Kitazono T
    Clin Exp Nephrol; 2017 Jun; 21(3):383-390. PubMed ID: 27339449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: a cohort study.
    Wei W; Li S; Liu J; Liu Y; Chen K; Chen S; Tu M; Chen H
    Diabetol Metab Syndr; 2022 Nov; 14(1):176. PubMed ID: 36419088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome.
    Wang J; Liu Y; Jin R; Zhao X; Wu Z; Han Z; Xu Z; Guo X; Tao L
    Nephrol Dial Transplant; 2024 Apr; 39(5):860-872. PubMed ID: 37930847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of renal function using cystatin C-based estimated glomerular filtration rate in patients with urothelial carcinoma treated with gemcitabine and cisplatin chemotherapy.
    Nishimura F; Ushijima T; Hamada S; Kadowaki D; Miyamura S; Oniki K; Saruwatari J
    J Clin Pharm Ther; 2021 Dec; 46(6):1622-1628. PubMed ID: 34339546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Kidney Graft Function Evolution Measured by Creatinine and Cystatin C.
    Ramos-Barron MA; Hernandez Bejarano I; Rodrigo E; Cruz Iglesias E; Benito Hernandez A; Agueros Blanco C; Morales Martin AI; Prieto Vicente M; Lopez Hernandez F; Arias M; Gomez-Alamillo C
    Transplant Proc; 2016 Nov; 48(9):2913-2916. PubMed ID: 27932106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study.
    Willey JZ; Moon YP; Husain SA; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
    PLoS One; 2020; 15(1):e0226509. PubMed ID: 31940363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C and Muscle Mass in Patients With Heart Failure.
    Ivey-Miranda JB; Inker LA; Griffin M; Rao V; Maulion C; Turner JM; Wilson FP; Tang WHW; Levey AS; Testani JM
    J Card Fail; 2021 Jan; 27(1):48-56. PubMed ID: 32750487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference intervals for serum cystatin C and factors influencing cystatin C levels other than renal function in the elderly.
    Wei L; Ye X; Pei X; Wu J; Zhao W
    PLoS One; 2014; 9(1):e86066. PubMed ID: 24465871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coefficient of Determination between Estimated and Measured Renal Function in Japanese Patients with Sarcopenia May Be Improved by Adjusting for Muscle Mass and Sex: A Prospective Study.
    Nakatani S; Maeda K; Akagi J; Ichigi M; Murakami M; Harada Y; Utsumi S; Fukunaga M; Narita Y; Kondo Y; Ishitsuka Y; Irie T; Kadowaki D; Hirata S
    Biol Pharm Bull; 2019 Aug; 42(8):1350-1357. PubMed ID: 31167988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of muscle mass on the estimation of glomerular filtration rate in Japanese terminal cancer patients.
    Uekuzu Y; Higashiguchi T; Futamura A; Chihara T; Usui M
    Clin Exp Nephrol; 2020 Oct; 24(10):876-884. PubMed ID: 32621075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of creatinine clearance rate estimated based on serum cystatin C in patients with acute kidney injury].
    Hu JT; Xie XL; Tang ZH; Li CQ; Zhou HW
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Sep; 24(9):534-7. PubMed ID: 22938661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of s-cystatin C for mortality after coronary artery bypass surgery.
    Dardashti A; Nozohoor S; Algotsson L; Ederoth P; Bjursten H
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):139-46. PubMed ID: 27056756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease.
    Lu YW; Tsai YL; Chou RH; Kuo CS; Chang CC; Huang PH; Lin SJ
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1509-1515. PubMed ID: 33810966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension.
    Salgado JV; França AK; Cabral NA; Lages J; Ribeiro VS; Santos AM; Salgado BJ
    Rev Assoc Med Bras (1992); 2013; 59(1):21-7. PubMed ID: 23440138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer.
    Hanna PE; Wang Q; Strohbehn IA; Moreno D; Harden D; Ouyang T; Katz-Agranov N; Seethapathy H; Reynolds KL; Gupta S; Leaf DE; Sise ME
    JAMA Netw Open; 2023 Jul; 6(7):e2321715. PubMed ID: 37405775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1.
    Shibata K; Yasuda Y; Kobayashi R; Ando Y; Shimokata T; Kamiya H; Hayashi M; Maruyama S; Matsuo S; Nakao M; Tsuchiya T; Teramachi H
    Clin Exp Nephrol; 2015 Dec; 19(6):1107-13. PubMed ID: 25894220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.